查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1570849

止泻药市场：按药物类型、治疗类型、分销管道、治疗类型划分 - 全球预测 2025-2030

Antidiarrhoeals Market by Drug Type (Bismuth Subsalicylate, Diphenoxylate, Loperamide), Treatment Type (Over-the-counter (OTC) Drugs, Prescription Drugs), Distribution Channel, Disease Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年止泻药市值为38.4亿美元，预计到2024年将达到40.3亿美元，复合年增长率为5.21%，到2030年将达到54.9亿美元。

止泻药是用来缓解腹泻症状、控制脱水和恢復电解质平衡的药物。这些药物的需求是由多种潜在原因引起的，包括感染疾病、食物不耐症和慢性疾病。适用于急性和慢性病例，在医院、诊所和居家照护等医疗环境中至关重要。最终用途范围包括直接消费者、医疗保健提供者和医疗机构。市场开拓主要受到全球胃肠道疾病盛行率不断上升、新兴国家健康意识提高和药品取得范围扩大的影响。潜在的机会包括开发针对特定病原体的新型止泻药、利用数位健康平台更好地管理患者以及扩大医疗需求未满足的新兴经济体的市场影响份额。主要建议包括投资研究以确定创新成分和输送系统，以及与科技公司建立策略伙伴关係以推动数位健康解决方案。

主要市场统计
基准年[2023] 38.4亿美元
预测年份 [2024] 40.3亿美元
预测年份 [2030] 54.9亿美元
复合年增长率（%） 5.21%

挑战包括严格的监管途径、长期使用的潜在副作用以及学名药的竞争导致价格压力。社会向自然和草药疗法的转变也可能对市场成长构成挑战，需要全面的临床试验来证实其主张。创新治疗领域应着重于个人化医疗，包括微生物组治疗，并利用人工智慧进行预测诊断和针对患者的治疗计画。此外，整合远端医疗有可能彻底改变止泻病人参与和治疗监测。

该市场的特点是竞争激烈，现有製药公司占据主导地位，而非专利製造商的进入不断增加。全球对医疗保健系统中具有成本效益的解决方案的需求需要创新的经营模式，以平衡负担能力与高品质的治疗选择。为了推动成长，公司应专注于其产品的可及性、差异化和永续性，以适应不断变化的消费者需求和监管环境。

市场动态：揭示快速发展的止泻药市场的关键市场洞察

供需的动态交互作用正在改变止泻药市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，以及如何减轻消费行为及其对製造成本的影响及其对采购趋势的影响。

波特五力：开拓止泻药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解止泻药市场的外部影响

外部宏观环境因素对止泻药市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解止泻药市场的竞争状况

对止泻药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵止泻药市场供应商绩效评估

FPNV定位矩阵是评估止泻药市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘止泻药市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，止泻药市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告提供了涵盖关键焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾。

2. 市场开拓：辨识新兴市场的成长机会，评估现有产业的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检视市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人消化器官系统健康问题增加
      • 消费者生活方式的变化和获得医疗保健的意识增强
      • 增加对新兴经济体卫生基础设施和研发的投资
    • 抑制因素
      • 药物临床分析相关的高成本
    • 机会
      • 针对特定族群的个人化医疗趋势正在兴起。
      • 非药物解决方案的技术进步
    • 任务
      • 不同地区监管严格、标准不规范
  • 市场区隔分析
    • 药物类型：洛哌丁胺作为急慢性腹泻一线治疗药物的使用增加
    • 分销管道：线上分销管道在精通技术的消费者中越来越受欢迎
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章止泻药市场：依药物类型

  • 介绍
  • 水杨酸铋
  • 地芬诺酯
  • 洛哌丁胺
  • 口服补液盐 (ORS)

第七章止泻药市场：依治疗类型

  • 介绍
  • 非处方药 (OTC)
  • 处方药

第八章止泻药市场：依通路划分

  • 介绍
  • 离线
  • 在线的

第九章止泻药市场：依疾病类型

  • 介绍
  • 急性腹泻
  • 慢性腹泻
  • 旅行者腹泻

第十章美洲止泻药市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太止泻市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲止泻市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 百时美施贵宝公司透过收购 Mirati Therapeutics 扩大产品组合
  • 战略分析和建议
Product Code: MRR-976C0ED91C3A

The Antidiarrhoeals Market was valued at USD 3.84 billion in 2023, expected to reach USD 4.03 billion in 2024, and is projected to grow at a CAGR of 5.21%, to USD 5.49 billion by 2030.

Antidiarrhoeals are medications used to alleviate symptoms of diarrhea, manage dehydration, and restore electrolyte balance. The need for these medications is driven by various underlying causes such as infections, food intolerances, and chronic diseases. They are applicable in both acute and chronic cases and are essential in healthcare settings, including hospitals, clinics, and at-home care. The end-use scope covers direct consumers, healthcare providers, and medical institutions. Market growth is primarily influenced by increasing global prevalence of gastrointestinal disorders, rising awareness about health, and the expansion of access to pharmaceuticals in developing regions. Potential opportunities lie in the development of novel antidiarrhoeal drugs targeting specific pathogens, leveraging digital health platforms for better patient management, and expanding market presence in emerging economies with unmet healthcare needs. Key recommendations include investing in research to identify innovative ingredients and delivery systems and forming strategic partnerships with technology firms to enhance digital healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 3.84 billion
Estimated Year [2024] USD 4.03 billion
Forecast Year [2030] USD 5.49 billion
CAGR (%) 5.21%

Challenges include stringent regulatory pathways, possible side effects of long-term medication use, and generic competition leading to price pressures. Societal shifts towards natural and herbal remedies may also challenge market growth, necessitating comprehensive clinical trials to substantiate claims. Areas of innovation should focus on personalized medicine, including microbiome therapeutics, and harnessing artificial intelligence for predictive diagnoses and patient-specific treatment plans. Additionally, the integration of telemedicine could revolutionize patient engagement and therapy monitoring for antidiarrhoeals.

The market is characterized by its competitive nature, with established pharmaceutical companies dominating alongside increasing participation from generic manufacturers. The push for cost-effective solutions in healthcare systems globally calls for innovative business models that balance affordability and high-quality treatment options. To foster growth, businesses should focus on accessibility, differentiation, and sustainability in product offerings, aligning with the evolving consumer demands and regulatory landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antidiarrhoeals Market

The Antidiarrhoeals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidents of digestive health issues in the geriatric population
    • Growing awareness about lifestyle changes and healthcare access among consumers
    • Rising investments in healthcare infrastructure and R&D in developing economies
  • Market Restraints
    • High cost associated with clinical analysis of drugs
  • Market Opportunities
    • Rising trends of personalized medicine tailored to specific demographics
    • Technological advancements for non-pharmacological solutions
  • Market Challenges
    • Non-standardization of strict regulations and standards across various geographies

Porter's Five Forces: A Strategic Tool for Navigating the Antidiarrhoeals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antidiarrhoeals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antidiarrhoeals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antidiarrhoeals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antidiarrhoeals Market

A detailed market share analysis in the Antidiarrhoeals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antidiarrhoeals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antidiarrhoeals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antidiarrhoeals Market

A strategic analysis of the Antidiarrhoeals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antidiarrhoeals Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Actelion Pharmaceuticals Ltd, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Cipla Limited, Daiichi Sankyo Company, Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Henry Schein, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Merck & Co., Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Procter & Gamble Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antidiarrhoeals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Bismuth Subsalicylate, Diphenoxylate, Loperamide, and Oral Rehydration Salts (ORS).
  • Based on Treatment Type, market is studied across Over-the-counter (OTC) Drugs and Prescription Drugs.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Disease Type, market is studied across Acute Diarrhoea, Chronic Diarrhoea, and Traveller's Diarrhoea.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidents of digestive health issues in the geriatric population
      • 5.1.1.2. Growing awareness about lifestyle changes and healthcare access among consumers
      • 5.1.1.3. Rising investments in healthcare infrastructure and R&D in developing economies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with clinical analysis of drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising trends of personalized medicine tailored to specific demographics
      • 5.1.3.2. Technological advancements for non-pharmacological solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Non-standardization of strict regulations and standards across various geographies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Growing use of loperamide in first-line treatment for acute and chronic diarrhea
    • 5.2.2. Distribution Channel: Increasing popularity of online distribution channels among tech-savvy consumers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antidiarrhoeals Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Bismuth Subsalicylate
  • 6.3. Diphenoxylate
  • 6.4. Loperamide
  • 6.5. Oral Rehydration Salts (ORS)

7. Antidiarrhoeals Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Over-the-counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. Antidiarrhoeals Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Antidiarrhoeals Market, by Disease Type

  • 9.1. Introduction
  • 9.2. Acute Diarrhoea
  • 9.3. Chronic Diarrhoea
  • 9.4. Traveller's Diarrhoea

10. Americas Antidiarrhoeals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Antidiarrhoeals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Antidiarrhoeals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bristol-Myers Squibb Company expanded its portfolio with the acquisition of Mirati Therapeutics
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Actelion Pharmaceuticals Ltd
  • 3. AstraZeneca PLC
  • 4. Bayer AG
  • 5. Bristol-Myers Squibb Company
  • 6. Cipla Limited
  • 7. Daiichi Sankyo Company, Limited
  • 8. Eli Lilly and Company
  • 9. F. Hoffmann-La Roche AG
  • 10. GlaxoSmithKline PLC
  • 11. Henry Schein, Inc.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Lupin Limited
  • 14. Merck & Co., Inc.
  • 15. Novartis International AG
  • 16. Perrigo Company PLC
  • 17. Pfizer Inc.
  • 18. Procter & Gamble Company
  • 19. Sanofi S.A.
  • 20. Sun Pharmaceutical Industries Ltd.
  • 21. Takeda Pharmaceutical Company Limited
  • 22. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIDIARRHOEALS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIDIARRHOEALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIDIARRHOEALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANTIDIARRHOEALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANTIDIARRHOEALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIDIARRHOEALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIDIARRHOEALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIDIARRHOEALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DIPHENOXYLATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY LOPERAMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ORAL REHYDRATION SALTS (ORS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHOEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY CHRONIC DIARRHOEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TRAVELLER'S DIARRHOEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ANTIDIARRHOEALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. ANTIDIARRHOEALS MARKET, FPNV POSITIONING MATRIX, 2023